WHO - WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations

01 June 2021 |

WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.

Read more at the link below.

MORE INFO

About Us
Profile
Board of Directors
Stakeholder Network
Contact

LOGIN